Medicaid

Latest KFF Health News Stories

Faxes and Snail Mail: Will Pandemic-Era Flaws Unleash Improved Health Technology?

KFF Health News Original

The covid-19 pandemic exposed how state and local governments’ severely outdated technology can hinder unemployment benefits, food stamps, Medicaid, vaccine registrations, and the flow of other critical information. Now, with hefty federal pandemic relief and unexpected tax windfalls, states may finally have the chance to revamp their information technology for health care and social services. But can they?

Left Behind: Medicaid Patients Say Rides to Doctors Don’t Always Come

KFF Health News Original

States are required to set up transportation to medical appointments for adults, children and people with disabilities enrolled in the Medicaid program, and contracts can be worth tens of millions of dollars for transportation companies. But patients say the companies that deliver those rides are showing up late — and sometimes not at all — leaving them in bad weather, disrupting their care and even causing injuries.

Clinics Say State’s New Medicaid Drug Program Will Force Them to Cut Services

KFF Health News Original

On Jan. 1, California started buying prescription drugs for its nearly 14 million Medicaid enrollees, a responsibility that had primarily been held by managed-care insurance plans. State officials estimate California will save hundreds of millions of dollars by flexing its purchasing power, but some health clinics expect to lose money.

South Dakota Voters to Decide Medicaid Expansion

KFF Health News Original

Despite state Republican leaders’ rigid opposition to expanding the health program designed for low-income residents, advocates successfully gathered enough signatures to get the measure on the fall ballot.

KHN’s ‘What the Health?’: Boosting Confusion

KFF Health News Original

Federal health officials appear poised to extend a recommendation for covid boosters to all adults, following moves by some governors and mayors to broaden the eligible booster pool as caseloads rise. Meanwhile, the Food and Drug Administration finally has a nominee to head the agency: former FDA chief Robert Califf. And Medicare premiums for consumers will likely rise substantially in 2022, partly due to the approval of a controversial drug to treat Alzheimer’s disease. Tami Luhby of CNN, Sarah Karlin-Smith of the Pink Sheet and Rachel Cohrs of Stat join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Dan Weissmann, host of the “An Arm and a Leg” podcast.

Medicare’s Open Enrollment Is Open Season for Scammers

KFF Health News Original

Medicare officials say complaints are rising from seniors lured into private plans with misleading information or enrolled without their consent. In response, officials have threatened to penalize the private companies selling Medicare Advantage and drug plans if they or agents working on their behalf mislead consumers.